-
1
-
-
33746920337
-
Advanced glycation end products: Sparking the development of diabetic vascular injury
-
A. Goldin, J.A. Beckman, A.M. Schmidt, and M.A. Creager Advanced glycation end products: Sparking the development of diabetic vascular injury Circulation 114 2006 597 605
-
(2006)
Circulation
, vol.114
, pp. 597-605
-
-
Goldin, A.1
Beckman, J.A.2
Schmidt, A.M.3
Creager, M.A.4
-
2
-
-
77950898257
-
The RAGE axis: A fundamental mechanism signaling danger to the vulnerable vasculature
-
S.F. Yan, R. Ramasamy, and A.M. Schmidt The RAGE axis: A fundamental mechanism signaling danger to the vulnerable vasculature Circ. Res. 106 2010 842 853
-
(2010)
Circ. Res.
, vol.106
, pp. 842-853
-
-
Yan, S.F.1
Ramasamy, R.2
Schmidt, A.M.3
-
3
-
-
84885153340
-
Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond
-
G. Daffu, C.H. delPozo, and K.M. O'Shea Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond Int. J. Mol. Sci. 14 2013 19891 19910
-
(2013)
Int. J. Mol. Sci.
, vol.14
, pp. 19891-19910
-
-
Daffu, G.1
DelPozo, C.H.2
O'Shea, K.M.3
-
4
-
-
84880176927
-
Nox as a target for diabetic complications
-
Y. Gorin, and K. Block Nox as a target for diabetic complications Clin. Sci. Lond. 125 2013 361 382
-
(2013)
Clin. Sci. Lond.
, vol.125
, pp. 361-382
-
-
Gorin, Y.1
Block, K.2
-
5
-
-
84896719110
-
Role of advanced glycation end products in cellular signaling
-
C. Ott, K. Jacobs, E. Haucke, A. Navarrete Santos, T. Grune, and A. Simm Role of advanced glycation end products in cellular signaling Redox Biol. 2 2014 411 429
-
(2014)
Redox Biol.
, vol.2
, pp. 411-429
-
-
Ott, C.1
Jacobs, K.2
Haucke, E.3
Navarrete Santos, A.4
Grune, T.5
Simm, A.6
-
6
-
-
84922654302
-
AGEs and chronic subclinical inflammation in diabetes: Disorders of immune system
-
H. Hu, H. Jiang, H. Ren, X. Hu, X. Wang, and C. Han AGEs and chronic subclinical inflammation in diabetes: Disorders of immune system Diabetes Metab. Res. Rev. 31 2015 127 137
-
(2015)
Diabetes Metab. Res. Rev.
, vol.31
, pp. 127-137
-
-
Hu, H.1
Jiang, H.2
Ren, H.3
Hu, X.4
Wang, X.5
Han, C.6
-
7
-
-
0036599334
-
Advanced glycation end products and endothelial dysfunction in type 2 diabetes
-
K.C. Tan, W.S. Chow, V.H. Ai, C. Metz, R. Bucala, and K.S. Lam Advanced glycation end products and endothelial dysfunction in type 2 diabetes Diabetes Care 25 2002 1055 1059
-
(2002)
Diabetes Care
, vol.25
, pp. 1055-1059
-
-
Tan, K.C.1
Chow, W.S.2
Ai, V.H.3
Metz, C.4
Bucala, R.5
Lam, K.S.6
-
8
-
-
84903698784
-
Role of AGEs-RAGE system in cardiovascular disease
-
K. Fukami, S. Yamagishi, and S. Okuda Role of AGEs-RAGE system in cardiovascular disease Curr. Pharm. Des. 20 2014 2395 2402
-
(2014)
Curr. Pharm. Des.
, vol.20
, pp. 2395-2402
-
-
Fukami, K.1
Yamagishi, S.2
Okuda, S.3
-
9
-
-
48249134831
-
RAGE and modulation of ischemic injury in the diabetic myocardium
-
L.G. Bucciarelli, R. Ananthakrishnan, Y.C. Hwang, M. Kaneko, F. Song, D.R. Sell, C. Strauch, V.M. Monnier, S.F. Yan, A.M. Schmidt, and R. Ramasamy RAGE and modulation of ischemic injury in the diabetic myocardium Diabetes 57 2008 1941 1951
-
(2008)
Diabetes
, vol.57
, pp. 1941-1951
-
-
Bucciarelli, L.G.1
Ananthakrishnan, R.2
Hwang, Y.C.3
Kaneko, M.4
Song, F.5
Sell, D.R.6
Strauch, C.7
Monnier, V.M.8
Yan, S.F.9
Schmidt, A.M.10
Ramasamy, R.11
-
10
-
-
52749084063
-
Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes
-
A. Soro-Paavonen, A.M. Watson, J. Li, K. Paavonen, A. Koitka, A.C. Calkin, D. Barit, M.T. Coughlan, B.G. Drew, G.I. Lancaster, M. Thomas, J.M. Forbes, P.P. Nawroth, A. Bierhaus, M.E. Cooper, and K.A. Jandeleit-Dahm Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes Diabetes 57 2008 2461 2469
-
(2008)
Diabetes
, vol.57
, pp. 2461-2469
-
-
Soro-Paavonen, A.1
Watson, A.M.2
Li, J.3
Paavonen, K.4
Koitka, A.5
Calkin, A.C.6
Barit, D.7
Coughlan, M.T.8
Drew, B.G.9
Lancaster, G.I.10
Thomas, M.11
Forbes, J.M.12
Nawroth, P.P.13
Bierhaus, A.14
Cooper, M.E.15
Jandeleit-Dahm, K.A.16
-
11
-
-
84919969049
-
Plasma advanced glycation end products are associated with incident cardiovascular events in individuals with type 2 diabetes: A case-cohort study with a median follow-up of 10 years (EPIC-NL)
-
N.M. Hanssen, J.W. Beulens, S. van Dieren, J.L. Scheijen, D.L. van der A, A.M. Spijkerman, Y.T. van der Schouw, C.D. Stehouwer, and C.G. Schalkwijk Plasma advanced glycation end products are associated with incident cardiovascular events in individuals with type 2 diabetes: A case-cohort study with a median follow-up of 10 years (EPIC-NL) Diabetes 64 2015 257 265
-
(2015)
Diabetes
, vol.64
, pp. 257-265
-
-
Hanssen, N.M.1
Beulens, J.W.2
Van Dieren, S.3
Scheijen, J.L.4
Van Der, A.D.L.5
Spijkerman, A.M.6
Van Der Schouw, Y.T.7
Stehouwer, C.D.8
Schalkwijk, C.G.9
-
12
-
-
67651099181
-
Regulation of advanced glycation end product (AGE)-receptor (RAGE) system by PPAR-gamma agonists and its implication in cardiovascular disease
-
S. Yamagishi, K. Nakamura, and T. Matsui Regulation of advanced glycation end product (AGE)-receptor (RAGE) system by PPAR-gamma agonists and its implication in cardiovascular disease Pharmacol. Res. 60 2009 174 178
-
(2009)
Pharmacol. Res.
, vol.60
, pp. 174-178
-
-
Yamagishi, S.1
Nakamura, K.2
Matsui, T.3
-
13
-
-
77952784059
-
Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: The effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor
-
S.H. Ihm, K. Chang, H.Y. Kim, S.H. Baek, H.J. Youn, K.B. Seung, and J.H. Kim Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: The effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor Basic Res. Cardiol. 105 2010 399 407
-
(2010)
Basic Res. Cardiol.
, vol.105
, pp. 399-407
-
-
Ihm, S.H.1
Chang, K.2
Kim, H.Y.3
Baek, S.H.4
Youn, H.J.5
Seung, K.B.6
Kim, J.H.7
-
14
-
-
51449089179
-
Telmisartan inhibits advanced glycation end products (AGEs)-elicited endothelial cell injury by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation
-
S. Yamagishi, T. Matsui, K. Nakamura, M. Takeuchi, and H. Inoue Telmisartan inhibits advanced glycation end products (AGEs)-elicited endothelial cell injury by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation Protein Pept. Lett. 15 2008 850 853
-
(2008)
Protein Pept. Lett.
, vol.15
, pp. 850-853
-
-
Yamagishi, S.1
Matsui, T.2
Nakamura, K.3
Takeuchi, M.4
Inoue, H.5
-
15
-
-
84921386189
-
Pioglitazone inhibits high glucose-induced expression of receptor for advanced glycation end products in coronary artery smooth muscle cells
-
B.B. Di, H.W. Li, W.P. Li, X.H. Shen, Z.J. Sun, and X. Wu Pioglitazone inhibits high glucose-induced expression of receptor for advanced glycation end products in coronary artery smooth muscle cells Mol. Med. Rep. 11 2015 2601 2607
-
(2015)
Mol. Med. Rep.
, vol.11
, pp. 2601-2607
-
-
Di, B.B.1
Li, H.W.2
Li, W.P.3
Shen, X.H.4
Sun, Z.J.5
Wu, X.6
-
16
-
-
0035805144
-
Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages
-
Y.C. Liang, S.H. Tsai, D.C. Tsai, S.Y. Lin-Shiau, and J.K. Lin Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages FEBS Lett. 496 2001 12 18
-
(2001)
FEBS Lett.
, vol.496
, pp. 12-18
-
-
Liang, Y.C.1
Tsai, S.H.2
Tsai, D.C.3
Lin-Shiau, S.Y.4
Lin, J.K.5
-
17
-
-
84901636216
-
Chrysin attenuates inflammation by regulating M1/M2 status via activating PPARγ
-
X. Feng, H. Qin, Q. Shi, Y. Zhang, F. Zhou, H. Wu, S. Ding, Z. Niu, Y. Lu, and P. Shen Chrysin attenuates inflammation by regulating M1/M2 status via activating PPARγ Biochem. Pharmacol. 89 2014 503 514
-
(2014)
Biochem. Pharmacol.
, vol.89
, pp. 503-514
-
-
Feng, X.1
Qin, H.2
Shi, Q.3
Zhang, Y.4
Zhou, F.5
Wu, H.6
Ding, S.7
Niu, Z.8
Lu, Y.9
Shen, P.10
-
18
-
-
84926126053
-
Chrysin and luteolin alleviate vascular complications associated with insulin resistance mainly through PPAR-γ activation
-
H.M. El-Bassossy, S.M. Abo-Warda, and A. Fahmy Chrysin and luteolin alleviate vascular complications associated with insulin resistance mainly through PPAR-γ activation Am. J. Chin. Med. 42 2014 1153 1167
-
(2014)
Am. J. Chin. Med.
, vol.42
, pp. 1153-1167
-
-
El-Bassossy, H.M.1
Abo-Warda, S.M.2
Fahmy, A.3
-
19
-
-
84928730981
-
Inhibition of TGF-β by a novel PPAR-γ agonist, chrysin, salvages β-receptor stimulated myocardial injury in rats through MAPKs-dependent mechanism
-
N. Rani, S. Bharti, J. Bhatia, A. Tomar, T.C. Nag, R. Ray, and D.S. Arya Inhibition of TGF-β by a novel PPAR-γ agonist, chrysin, salvages β-receptor stimulated myocardial injury in rats through MAPKs-dependent mechanism Nutr. Metab. Lond. 12 2015 11
-
(2015)
Nutr. Metab. Lond.
, vol.12
, pp. 11
-
-
Rani, N.1
Bharti, S.2
Bhatia, J.3
Tomar, A.4
Nag, T.C.5
Ray, R.6
Arya, D.S.7
-
20
-
-
84886288001
-
Chrysin and luteolin attenuate diabetes-induced impairment in endothelial-dependent relaxation: Effect on lipid profile, AGEs and NO generation
-
H.M. El-Bassossy, S.M. Abo-Warda, and A. Fahmy Chrysin and luteolin attenuate diabetes-induced impairment in endothelial-dependent relaxation: Effect on lipid profile, AGEs and NO generation Phytother. Res. 27 2013 1678 1684
-
(2013)
Phytother. Res.
, vol.27
, pp. 1678-1684
-
-
El-Bassossy, H.M.1
Abo-Warda, S.M.2
Fahmy, A.3
-
21
-
-
84902245181
-
Chrysin, an anti-inflammatory molecule, abrogates renal dysfunction in type 2 diabetic rats
-
A. Ahad, A.A. Ganai, M. Mujeeb, and W.A. Siddiqui Chrysin, an anti-inflammatory molecule, abrogates renal dysfunction in type 2 diabetic rats Toxicol. Appl. Pharmacol. 279 2014 1 7
-
(2014)
Toxicol. Appl. Pharmacol.
, vol.279
, pp. 1-7
-
-
Ahad, A.1
Ganai, A.A.2
Mujeeb, M.3
Siddiqui, W.A.4
-
22
-
-
0014606996
-
Diabetogenic action of streptozotocin: Relationship of dose to metabolic response
-
A. Junod, A.E. Lambert, W. Stauffacher, and A.E. Renold Diabetogenic action of streptozotocin: Relationship of dose to metabolic response J. Clin. Investig. 48 1969 2129 2139
-
(1969)
J. Clin. Investig.
, vol.48
, pp. 2129-2139
-
-
Junod, A.1
Lambert, A.E.2
Stauffacher, W.3
Renold, A.E.4
-
23
-
-
84949845094
-
Challenges and issues with streptozotocin-induced diabetes - A clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics
-
S.N. Goyal, N.M. Reddy, K.R. Patil, K.T. Nakhate, S. Ojha, C.R. Patil, and Y.O. Agrawal Challenges and issues with streptozotocin-induced diabetes - A clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics Chem. Biol. Interact. 244 2016 49 63
-
(2016)
Chem. Biol. Interact.
, vol.244
, pp. 49-63
-
-
Goyal, S.N.1
Reddy, N.M.2
Patil, K.R.3
Nakhate, K.T.4
Ojha, S.5
Patil, C.R.6
Agrawal, Y.O.7
-
24
-
-
0018384650
-
Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction
-
H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 95 1979 351 358
-
(1979)
Anal. Biochem.
, vol.95
, pp. 351-358
-
-
Ohkawa, H.1
Ohishi, N.2
Yagi, K.3
-
25
-
-
0018327389
-
Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver
-
M.S. Moron, J.W. Depierre, and B. Mannervik Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver Biochim. Biophys. Acta 582 1979 67 78
-
(1979)
Biochim. Biophys. Acta
, vol.582
, pp. 67-78
-
-
Moron, M.S.1
Depierre, J.W.2
Mannervik, B.3
-
26
-
-
0020448709
-
Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids
-
L.C. Green, D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, and S.R. Tannenbaum Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids Anal. Biochem. 126 1982 131 138
-
(1982)
Anal. Biochem.
, vol.126
, pp. 131-138
-
-
Green, L.C.1
Wagner, D.A.2
Glogowski, J.3
Skipper, P.L.4
Wishnok, J.S.5
Tannenbaum, S.R.6
-
27
-
-
0000024078
-
Catalase
-
H.U. Bergmeyer, Academic Press Inc. New York
-
H. Aebi Catalase H.U. Bergmeyer, Methods of Enzymatic Analysis 1974 Academic Press Inc. New York 673 685
-
(1974)
Methods of Enzymatic Analysis
, pp. 673-685
-
-
Aebi, H.1
-
28
-
-
84891957173
-
Regulation of heat shock proteins 27 and 70, p-Akt/p-eNOS and MAPKs by Naringin Dampens myocardial injury and dysfunction in vivo after ischemia/reperfusion
-
N. Rani, S. Bharti, M. Manchanda, T.C. Nag, R. Ray, S.S. Chauhan, S. Kumari, and D.S. Arya Regulation of heat shock proteins 27 and 70, p-Akt/p-eNOS and MAPKs by Naringin Dampens myocardial injury and dysfunction in vivo after ischemia/reperfusion Plos One 8 2013 e82577
-
(2013)
Plos One
, vol.8
, pp. e82577
-
-
Rani, N.1
Bharti, S.2
Manchanda, M.3
Nag, T.C.4
Ray, R.5
Chauhan, S.S.6
Kumari, S.7
Arya, D.S.8
-
29
-
-
84924114114
-
5-HT2B receptor blockade attenuates β-adrenergic receptor-stimulated myocardial remodeling in rats via inhibiting apoptosis: Role of MAPKs and HSPs
-
S. Bharti, N. Rani, J. Bhatia, and D.S. Arya 5-HT2B receptor blockade attenuates β-adrenergic receptor-stimulated myocardial remodeling in rats via inhibiting apoptosis: Role of MAPKs and HSPs Apoptosis 20 2015 455 465
-
(2015)
Apoptosis
, vol.20
, pp. 455-465
-
-
Bharti, S.1
Rani, N.2
Bhatia, J.3
Arya, D.S.4
-
30
-
-
11244309512
-
Vasorelaxing effects of flavonoids: Investigation on the possible involvement of potassium channels
-
V. Calderone, S. Chericoni, C. Martinelli, L. Testai, A. Nardi, I. Morelli, M.C. Breschi, and E. Martinotti Vasorelaxing effects of flavonoids: Investigation on the possible involvement of potassium channels NaunynSchmiedebergs Arch. Pharmacol. 370 2004 290 298
-
(2004)
NaunynSchmiedebergs Arch. Pharmacol.
, vol.370
, pp. 290-298
-
-
Calderone, V.1
Chericoni, S.2
Martinelli, C.3
Testai, L.4
Nardi, A.5
Morelli, I.6
Breschi, M.C.7
Martinotti, E.8
-
31
-
-
10644296918
-
Effects of the dietary flavonoid chrysin in isolated rat mesenteric vascular bed
-
I.C. Villar, M. Galisteo, R. Vera, F. O'Valle, M.F. García-Saura, A. Zarzuelo, and J. Duarte Effects of the dietary flavonoid chrysin in isolated rat mesenteric vascular bed J. Vasc. Res. 41 2004 509 516
-
(2004)
J. Vasc. Res.
, vol.41
, pp. 509-516
-
-
Villar, I.C.1
Galisteo, M.2
Vera, R.3
O'Valle, F.4
García-Saura, M.F.5
Zarzuelo, A.6
Duarte, J.7
-
32
-
-
44649151707
-
The PPAR trio: Regulators of myocardial energy metabolism in health and disease
-
J.A. Madrazo, and D.P. Kelly The PPAR trio: Regulators of myocardial energy metabolism in health and disease J. Mol. Cell. Cardiol. 44 2008 968 975
-
(2008)
J. Mol. Cell. Cardiol.
, vol.44
, pp. 968-975
-
-
Madrazo, J.A.1
Kelly, D.P.2
-
33
-
-
84864864825
-
PPAR-γ as a therapeutic target in cardiovascular disease: Evidence and uncertainty
-
J.V. Huang, C.R. Greyson, and G.G. Schwartz PPAR-γ as a therapeutic target in cardiovascular disease: Evidence and uncertainty J. Lipid Res. 53 2012 1738 1754
-
(2012)
J. Lipid Res.
, vol.53
, pp. 1738-1754
-
-
Huang, J.V.1
Greyson, C.R.2
Schwartz, G.G.3
-
34
-
-
84877329207
-
PPARγ signaling and metabolism: The good, the bad and the future
-
M. Ahmadian, J.M. Suh, N. Hah, C. Liddle, A.R. Atkins, M. Downes, and R.M. Evans PPARγ signaling and metabolism: The good, the bad and the future Nat. Med. 19 2013 557 566
-
(2013)
Nat. Med.
, vol.19
, pp. 557-566
-
-
Ahmadian, M.1
Suh, J.M.2
Hah, N.3
Liddle, C.4
Atkins, A.R.5
Downes, M.6
Evans, R.M.7
-
35
-
-
85047682479
-
Hepatoprotective effect of chrysin on prooxidant-antioxidant status during ethanol-induced toxicity in female albino rats
-
J. Sathiavelu, G.J. Senapathy, R. Devaraj, and N. Namasivayam Hepatoprotective effect of chrysin on prooxidant-antioxidant status during ethanol-induced toxicity in female albino rats J. Pharm. Pharmacol. 61 2009 809 817
-
(2009)
J. Pharm. Pharmacol.
, vol.61
, pp. 809-817
-
-
Sathiavelu, J.1
Senapathy, G.J.2
Devaraj, R.3
Namasivayam, N.4
-
36
-
-
84890502277
-
Evaluation of the anti-atherogenic potential of chrysin in Wistar rats
-
R. Anandhi, P.A. Thomas, and P. Geraldine Evaluation of the anti-atherogenic potential of chrysin in Wistar rats Mol. Cell. Biochem. 385 2014 103 113
-
(2014)
Mol. Cell. Biochem.
, vol.385
, pp. 103-113
-
-
Anandhi, R.1
Thomas, P.A.2
Geraldine, P.3
-
37
-
-
84896698569
-
Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis
-
E.M. Mantawy, W.M. El-Bakly, A. Esmat, A.M. Badr, and E. El-Demerdash Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis Eur. J. Pharmacol. 728 2014 107 118
-
(2014)
Eur. J. Pharmacol.
, vol.728
, pp. 107-118
-
-
Mantawy, E.M.1
El-Bakly, W.M.2
Esmat, A.3
Badr, A.M.4
El-Demerdash, E.5
-
38
-
-
84903453976
-
Chrysin, apigenin and acacetin inhibit tumor necrosis factor-related apoptosis-inducing ligand receptor-1 (TRAIL-R1) on activated RAW264.7 macrophages
-
M. Warat, E. Szliszka, I. Korzonek-Szlacheta, W. Król, and Z.P. Czuba Chrysin, apigenin and acacetin inhibit tumor necrosis factor-related apoptosis-inducing ligand receptor-1 (TRAIL-R1) on activated RAW264.7 macrophages Int. J. Mol. Sci. 15 2014 11510 11522
-
(2014)
Int. J. Mol. Sci.
, vol.15
, pp. 11510-11522
-
-
Warat, M.1
Szliszka, E.2
Korzonek-Szlacheta, I.3
Król, W.4
Czuba, Z.P.5
-
39
-
-
84962520604
-
Chrysin attenuates cardiomyocyte apoptosis and loss of intermediate filaments in a mouse model of mitoxantrone cardiotoxicity
-
N. Anghel, C. Cotoraci, A. Ivan, M. Suciu, H. Herman, C. Balta, L. Nicolescu, T. Olariu, Z. Galajda, A. Ardelean, and A. Hermenean Chrysin attenuates cardiomyocyte apoptosis and loss of intermediate filaments in a mouse model of mitoxantrone cardiotoxicity Histol. Histopathol. 26 2015 11641
-
(2015)
Histol. Histopathol.
, vol.26
, pp. 11641
-
-
Anghel, N.1
Cotoraci, C.2
Ivan, A.3
Suciu, M.4
Herman, H.5
Balta, C.6
Nicolescu, L.7
Olariu, T.8
Galajda, Z.9
Ardelean, A.10
Hermenean, A.11
|